Adjuvant Intensification for LAR
NCT07407517
·
clinicaltrials.gov ↗
PHASE3
Phase
NOT_YET_RECRUITING
Status
904
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer Females
Triple Negative Breast Cancer (TNBC)
Interventions
DRUG:
Everolimus 10 mg daily
Sponsor
Fudan University